Seeking Alpha

United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe,...

United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe, has received approval from French regulators for its New Drug Application for Intravenous Remodulin for the treatment of pulmonary arterial hypertension.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs